Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma

作者:Chihara Dai; Westin Jason R; Miranda Roberto N; Cheah Chan Y; Oki Yasuhiro; Turturro Francesco; Romaguera Jorge E; Neelapu Sattva S; Nastoupil Lorreta J; Fayad Luis E; Rodriguez M Alma; Fowler Nathan H; Orlowski Robert Z; Wang Michael; Hagemeister Fredrick B; Medeiros L Jeffrey; F****e Michelle A
来源:British Journal of Haematology, 2017, 179(3): 503-506.
DOI:10.1111/bjh.14226